Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Waters Corporation. (6/16/14). "Press Release: Waters and Prosolia Sign Exclusive Agreement for DESI Technology for Clinical Mass Spectrometry Applications". Baltimore, MD.

Organisations Organisation Waters Corporation (NYSE: WAT)
  Group Waters (Group)
  Organisation 2 Prosolia Inc.
Products Product DESI technology (desorption electrospray ionisation)
  Product 2 Synapt® G2-Si system
Index term Index term Waters–Prosolia: ionisation technology, 201406– acquisition excl rights €na to use DESI for clinical research applications with Waters ToF MS systems
Persons Person Khanna, Rohit (Waters 201601– SVP Applied Technology before VP Worldwide Marketing)
  Person 2 Wiseman, Justin M. (Prosolia 201106 CEO joined 2007 as Director R&D before Purdue Univ before Lilly)
     


Prosolia DESI Technology Now Available on SYNAPT G2 Si and Xevo G2-XS QTof Mass Spectrometers


Waters Corporation (NYSE:WAT) has signed an agreement with Prosolia, Inc. (Indianapolis, IN) for the exclusive rights to DESI (Desorption Electrospray Ionization) technology for clinical research applications for use with Waters® time-of-flight mass spectrometers, including its SYNAPT® G2 Si and Xevo® G2-XS QTof mass spectrometers. The announcement came at the 62nd conference of the American Society of Mass Spectrometry (ASMS).

When used for clinical research studies, DESI is a non-destructive means by which researchers using mass spectrometry can determine, with specificity and speed, the molecular distributions of drugs, lipids and metabolites from human tissue samples. Otherwise known as in vitro "tissue imaging", it allows scientists to potentially distinguish healthy tissue from diseased tissue.

"By combining Prosolia's DESI with Waters' time-of-flight mass spectrometers, we see the potential to advance clinical research in meaningful ways," said Dr. Rohit Khanna, Vice President of Worldwide Marketing and Informatics for the Waters Division. "This agreement with Prosolia is an important step in fulfilling our vision of improving human health by partnering with the biomedical community to make breakthrough scientific discoveries and translate them into healthcare solutions."

A bottleneck in life science research is the time and expertise required for sample preparation. Tissue sample preparation can be a tedious process that often involves multiple steps, delaying the time to a result, decreasing productivity and increasing the probability for error. DESI eliminates this bottleneck by enabling direct, automated analysis of tissue samples thereby reducing the requirement for extensive sample preparation and enabling high throughput sample analysis. These capabilities translate into lower laboratory operational costs, streamlined workflows and generate results faster than traditional approaches.

"Waters is a natural choice for Prosolia to partner with to advance the DESI technology in the clinical research space," said Dr. Justin Wiseman, Chairman, President & CEO of Prosolia. "Waters' mass spectrometry technology and vision of a healthier future for humanity appealed to us on many levels and we are looking forward to a long and successful relationship."

Financial terms of the agreement were not disclosed.


About Prosolia, Inc. (www.prosolia.com)

Prosolia is a privately-held scientific instruments company engaged in the development and marketing of analytical tools that enhance and expand the use of mass spectrometers. Our portfolio of scientific tools includes innovative sample introduction and surface analysis systems and intuitive software, all of which are part of workflows that reduce complexity and accelerate results. Our innovative direct analysis solutions and technologies allow customers to realize superior performance towards actionable results with increased cost efficiencies.


About Waters Corporation (www.waters.com)

For more than 50 years, Waters Corporation has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality, consumer products and high-value added chemicals worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.9 billion in 2013, Waters is driving scientific discovery and operational excellence for customers worldwide.

###

Waters, Xevo and Synapt are trademarks of Waters Corporation. Prosolia is a trademark of Prosolia, Inc.

Waters Corporate Contacts
Media Contact
Brian J. Murphy
Public Relations
+1 508-482-2614
brian_j_murphy@waters.com

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Waters (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px